|
gptkbp:instanceOf
|
patent
|
|
gptkbp:hasAbstract
|
This patent describes a method for treating cancer using a specific compound.
|
|
gptkbp:hasAssignee
|
gptkb:XYZ_Biotech
gptkb:ABC_Pharmaceuticals
|
|
gptkbp:hasClaim
|
20 claims
|
|
gptkbp:hasCollaborationsWith
|
with_DEF_Corp.
|
|
gptkbp:hasCompetitors
|
first in class
|
|
gptkbp:hasCountry
|
gptkb:United_States
|
|
gptkbp:hasDepartment
|
breast cancer
|
|
gptkbp:hasDescription
|
The invention relates to a method for treating cancer.
|
|
gptkbp:hasExaminer
|
Jane_Smith
|
|
gptkbp:hasExhibition
|
Yes
|
|
gptkbp:hasFeature
|
promising
|
|
gptkbp:hasFieldOfUse
|
oncology
pharmaceutical compositions
|
|
gptkbp:hasFilingDate
|
2004-02-06
|
|
gptkbp:hasFilm
|
nausea
|
|
gptkbp:hasFunding
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:hasGoals
|
international
3 drawings
|
|
gptkbp:hasImpactOn
|
high
|
|
gptkbp:hasInternationalClassification
|
A61K 31/00
|
|
gptkbp:hasInventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
|
gptkbp:hasLegalStatus
|
Active
licensed
|
|
gptkbp:hasLocalCuisine
|
NCT01234567
|
|
gptkbp:hasMerchandise
|
inhibits tumor growth
|
|
gptkbp:hasOccupation
|
FDA_approved
|
|
gptkbp:hasPartnershipsWith
|
commercialized
|
|
gptkbp:hasPatentNumber
|
6,789,972
|
|
gptkbp:hasPerformedAt
|
oral
|
|
gptkbp:hasPopulation
|
adults
|
|
gptkbp:hasPriorityDate
|
2004-09-14
2024-02-06
2003-02-06
|
|
gptkbp:hasPrograms
|
acceptable
|
|
gptkbp:hasPublications
|
2004-02-06
2004/0123456 A1
|
|
gptkbp:hasRelatedPatent
|
new compound
US_60/123,456
|
|
gptkbp:hasResearchInterest
|
gptkb:University_of_Medicine
cancer therapy
clinical phase 2
|
|
gptkbp:hasSpecialty
|
patent protected
|
|
gptkbp:hasTechnicalField
|
medical treatment
|
|
gptkbp:hasTheme
|
20 years
|
|
gptkbp:hasTitle
|
Method for treating cancer
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,972 C19
|
|
gptkbp:isCitedBy
|
gptkb:US_7,123,456
|
|
gptkbp:isRelatedTo
|
gptkb:US_6,123,456
|
|
gptkbp:market
|
2020-01-01
available
|
|
gptkbp:provides
|
oncology
|
|
gptkbp:route
|
oral
|